SCHEMBL24702157

SCHEMBL24702157

CC(C)(C)OC(=O)N[C@@H](Cc1c[nH]c2ccccc12)CN1C(=O)c2ccccc2C1O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC3 O15379 5/20 0.52
▸ HDAC4 P56524 5/20 0.52
▸ HDAC1 Q13547 5/20 0.52
▸ HDAC7 Q8WUI4 5/20 0.52
▸ HDAC2 Q92769 5/20 0.52
▸ HDAC10 Q969S8 5/20 0.52
▸ HDAC11 Q96DB2 5/20 0.52
▸ HDAC8 Q9BY41 5/20 0.52
▸ HDAC6 Q9UBN7 5/20 0.52
▸ HDAC9 Q9UKV0 5/20 0.52
▸ HDAC5 Q9UQL6 5/20 0.52
▸ CTSL P07711 3/20 0.50
▸ TACR1 P25103 2/20 0.50
▸ CTSS P25774 1/20 0.50
▸ CTSK P43235 1/20 0.50
▸ CCKAR P32238 1/20 0.48
▸ CCKBR P32239 1/20 0.48
▸ MAPT P10636 3/20 0.48
▸ TP53 P04637 1/20 0.48
▸ SSTR3 P32745 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24787792 0.90 HDAC3 (0.46) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL24702172 0.85 CTSL (0.55) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL21466552 0.85 CTSL (0.55) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL21466530 0.85 CTSL (0.55) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL12719469 0.82 ATM (0.53) CTSLCTSSCTSKCCKARCCKBR
SCHEMBL23653517 0.79 LMNA (0.42) CCKARCCKBRTP53SMN1; SMN2
SCHEMBL3560147 0.78 CTSL (0.63) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL6409052 0.78 CTSL (0.63) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL29401065 0.78 CTSL (0.63) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL29398124 0.78 CTSL (0.63) HDAC3HDAC4HDAC1HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4101855-B1 ANTITUMORAL COMPOUNDS PHARMA MAR SA (ES) 2023-08-02 — — EP disclosed
EP-4101855-A1 ANTITUMORAL COMPOUNDS Pharma Mar S.A. (ES) 2022-12-14 — — EP disclosed
Send feedback